Experimental modelling of Alzheimer's disease for therapeutic screening
Neurodegenerative diseases, including Alzheimer's disease (AD), pose a significant and urgent challenge to healthcare systems worldwide. With an increasing life expectancy, these progressive age-related disorders are expected to rise exponentially. No cure currently exists for AD, and the aetio...
Saved in:
Main Authors: | Laura Blaikie (Author), Graeme Kay (Author), Patricia Maciel (Author), Paul Kong Thoo Lin (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deep learning-based drug screening for the discovery of potential therapeutic agents for Alzheimer's disease
by: Tong Wu, et al.
Published: (2024) -
Targeting Synaptic Plasticity in Experimental Models of Alzheimer's Disease
by: Dalila Mango, et al.
Published: (2019) -
Experimental Pharmacology in Transgenic Rodent Models of Alzheimer's Disease
by: A. Claudio Cuello, et al.
Published: (2019) -
Integrating experimentation and quantitative modeling to enhance discovery of beta amyloid (Aβ) lowering therapeutics for Alzheimer's disease
by: Yasong eLu
Published: (2012) -
Multi-Target Screening and Experimental Validation of Natural Products from Selaginella Plants against Alzheimer's Disease
by: Yin-Hua Deng, et al.
Published: (2017)